Vaginal Microbiome Variation and Bacterial Vaginosis

NewsGuard 100/100 Score

By forming a mutual relationship with the host, the vaginal microbiome (i.e. various kinds of vaginal microbial communities present in healthy women) has a significant impact on women’s health and disease. In the recent years our knowledge of those vaginal bacteria communities has expanded rapidly as a consequence of using modern molecular (cultivation-independent) methods for species identification.

Bacterial vaginosis represents the most prevalent type of vaginal infection that occurs among reproductive-age women, and also the most common condition that prompts women to seek medical care. This condition, which is highly dependent on resident microbial flora, is linked to some severe sequelae such as pelvic inflammatory disease, preterm labor, as well as increased sensitivity to infection with various sexually-transmitted agents.

A Shift in Vaginal Microbial Communities

Although the term ‘bacterial vaginosis’ was coined more than half a century ago, its etiology and natural history remains elusive. Generally, this condition is characterized by a shift in microbial composition from an abundance of lactobacilli in healthy women, to an increase of commensal anaerobic bacteria (such as Gardnerella, Atopobium, Prevotella and a panoply of other species).

As the aforementioned loss of lactobacilli results in reduced lactic acid production, the pH in the vaginal lumen increases. Furthermore, amine and salidase production increases, while the production of hydrogen peroxide and lactocin is diminished, leading to signs and symptoms of bacterial vaginosis.

Women with this condition are characterized by heterogeneous communities of bacteria that exhibit increased richness and diversity of existent bacterial species. Such species heterogeneity in bacterial vaginosis is thought to arise from functional redundancy between them, which is in turn associated with improved community reliability when faced with environmental changes.

Moreover, a thorough analysis of the vaginal microbiome may predict the recurrence of bacterial vaginosis if changes in the resident microflora are compared. Such recurrences in sexually-active women are not rare, and may even appear three times or more during the year.

Microbiome Research and Women's Health | Jennifer Fettweis | TEDxRVAWomen

Microbial Associations with Clinical Criteria for Bacterial Vaginosis

In a majority of clinical settings, women are diagnosed with bacterial vaginosis by using the Amsel criteria when three or more signs are present, such as a vaginal pH higher than 4.5, thin vaginal discharge, amine odor if potassium hydroxide is added to vaginal fluid, as well as the presence of vaginal epithelial cells overlaid with bacteria (also known as “clue cells”).

Nugent scores that are based on weighted tallies of various cellular morphotypes (most notably lactobacilli, Gardnerella vaginalis, Bacteroides, as well as curved Gram-variable rod-shaped bacteria) are also widely used in the diagnosis of bacterial vaginosis. This scoring system ranges from 0-10, and scores higher than 7 are indicative of bacterial vaginosis.

The advantage of these clinical criteria is that the diagnosis can be achieved by using light microscopy; however, that way it is impossible to get deep insights into the composition of present bacterial communities. On the other hand, deep sequencing analysis is quite expensive and still not pervasive in clinical practice, even though it can provide a clear picture of vaginal microbiota and allow the detection of recurrences and treatment failures.

Further Reading

Last Updated: Feb 26, 2019

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2019, February 26). Vaginal Microbiome Variation and Bacterial Vaginosis. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/health/Vaginal-Microbiome-Variation-and-Bacterial-Vaginosis.aspx.

  • MLA

    Meštrović, Tomislav. "Vaginal Microbiome Variation and Bacterial Vaginosis". News-Medical. 19 April 2024. <https://www.news-medical.net/health/Vaginal-Microbiome-Variation-and-Bacterial-Vaginosis.aspx>.

  • Chicago

    Meštrović, Tomislav. "Vaginal Microbiome Variation and Bacterial Vaginosis". News-Medical. https://www.news-medical.net/health/Vaginal-Microbiome-Variation-and-Bacterial-Vaginosis.aspx. (accessed April 19, 2024).

  • Harvard

    Meštrović, Tomislav. 2019. Vaginal Microbiome Variation and Bacterial Vaginosis. News-Medical, viewed 19 April 2024, https://www.news-medical.net/health/Vaginal-Microbiome-Variation-and-Bacterial-Vaginosis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Understanding the impact of HPV on the vaginal microbiome and its role in cervical cancer